Literature DB >> 32414839

Stability of SARS-CoV-2 in Phosphate-Buffered Saline for Molecular Detection.

Garrett A Perchetti1, Meei-Li Huang1, Vikas Peddu1, Keith R Jerome1,2, Alexander L Greninger3,2.   

Abstract

Entities:  

Keywords:  COVID-19; PBS; SARS-CoV-2; coronavirus; molecular detection; refrigeration; specimen stability; transport media

Mesh:

Substances:

Year:  2020        PMID: 32414839      PMCID: PMC7383534          DOI: 10.1128/JCM.01094-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.

LETTER

RNA viruses often require “cold chains” of transportation to prevent the breakdown of genetic material. The logistics of getting samples from the patient to a diagnostic laboratory, sometimes thousands of miles away from the original collection site, can be complex and resource intensive (1, 2). Nucleic acid degradation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can compromise the accuracy of molecular detection methods. It has been demonstrated that nasopharyngeal specimens containing SARS-CoV-2 can be stored in phosphate-buffered saline (PBS) as a substitute for viral transport medium (VTM) for up to 7 days (3). Here, we evaluate the stability of differing viral loads of SARS-CoV-2 over 28 days stored at room temperature, 4°C, –20°C, or –80°C. We used the first SARS-CoV-2-positive nasopharyngeal swab detected in our laboratory for spike-in material. PBS spiked with this SARS-CoV-2 specimen was stored in quadruplicates and divided into two concentrations, namely, 5,000 to 10,000 copies/ml (high titer) and 500 to 1,000 copies/ml (low titer), as determined by droplet digital reverse transcriptase PCR (RT-PCR). Nucleic acids were isolated on the Roche MagNA Pure96 system (Basel, Switzerland). Qualitative RT-PCR (qRT-PCR) was performed on 448 samples using our CDC-based laboratory-developed test, as described previously (4, 5). For the high concentration of SARS-CoV-2, regardless of storage conditions, 100% of samples were detected by qRT-PCR through day 28. At room temperature, median cycle threshold (C) values for lower titers for both N1 and N2 targets remained consistent through day 28, fluctuating less than 1 median C (Table 1). For lower concentrations of virus, storage at room temperature was associated with reductions of positivity beginning at day 7, and by day 28, 0% of samples were detected for N1. Storage at room temperature was the least stable of all environmental conditions tested, with 54.2% of negative PCR results.
TABLE 1

Median C values for N1 and N2 targets

Storage condition by target and titerMedian CT value
Day 0Day 1Day 2Day 7Day 14Day 21Day 28
N1
    5,000–10,000 copies/ml
        Room temp31.431.031.531.231.631.431.3
        4°C30.830.931.331.531.731.531.4
        −20°C30.931.431.731.231.731.831.8
        −80°C30.731.131.431.031.030.931.8
    500–1,000 copies/ml
        Room temp33.436.836.336.1 (3/4)b 35.8 (3/4)35.2 (1/4)NDET (0/4)
        4°C34.434.935.135.935.935.8 (3/4)36.5
        −20°C34.235.236.036.537.5 (1/4)37.437.3 (3/4)
        −80°C35.134.435.334.936.236.435.3
N2
    5,000–10,000 copies/ml
        Room temp30.630.430.930.931.131.131.2
        4°C30.430.230.530.631.330.631.1
        −20°C30.630.530.930.631.630.931.2
        −80°C30.630.530.630.630.630.531.2
    500–1,000 copies/ml
        Room temp32.835.035.836.6 (3/4)37.038.3 (2/4)38.3 (3/4)
        4°C33.834.234.734.9 (3/4)36.035.436.4
        −20°C33.735.336.037.8 (3/4)36.736.3 (3/4)37.0 (3/4)
        −80°C34.433.734.835.735.834.735.9

C, cycle threshold; NDET, not detected. N1 and N2 are amplicons within the nucleocapsid gene of SARS-CoV-2.

Parentheticals denote the number of samples that were detected at a condition only if the 4 replicates were not all detected.

Median C values for N1 and N2 targets C, cycle threshold; NDET, not detected. N1 and N2 are amplicons within the nucleocapsid gene of SARS-CoV-2. Parentheticals denote the number of samples that were detected at a condition only if the 4 replicates were not all detected. At 4°C, there was minimal change in Cs over time at the higher viral concentration. For lower titers, Cs increased by 2.1 Cs for N1 and 2.6 Cs for N2 over the 28 days. At –20°C, lower titers of virus fluctuated slightly more, increasing by ≥3 Cs. Storage of SARS-CoV-2 in PBS at –20°C was the second least stable condition, accounting for 37.5% of negative PCR results. Storage at –80°C showed the greatest stability, with all samples detected throughout the 28 days and ≤1.5 median Cs for both N1 and N2 targets. Here, we show that the stability of SARS-CoV-2 can be maintained at 4°C for up to a month when –80°C storage is not available (6, 7). At viral loads of >5,000 copies/ml—corresponding to >75% of positive samples recovered in our clinical lab to date—different storage temperatures did not have a substantial impact on our ability to detect SARS-CoV-2 when stored in PBS.
  7 in total

Review 1.  Sample transportation - an overview.

Authors:  Mads Nybo; Janne Cadamuro; Michael P Cornes; Rubén Gómez Rioja; Kjell Grankvist
Journal:  Diagnosis (Berl)       Date:  2019-03-26

2.  Impact of RNA degradation on gene expression profiling.

Authors:  Lennart Opitz; Gabriela Salinas-Riester; Marian Grade; Klaus Jung; Peter Jo; Georg Emons; B Michael Ghadimi; Tim Beissbarth; Jochen Gaedcke
Journal:  BMC Med Genomics       Date:  2010-08-09       Impact factor: 3.063

3.  Comparison of Commercially Available and Laboratory-Developed Assays for In Vitro Detection of SARS-CoV-2 in Clinical Laboratories.

Authors:  Joshua A Lieberman; Gregory Pepper; Samia N Naccache; Meei-Li Huang; Keith R Jerome; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

Review 4.  Stability and infectivity of coronaviruses in inanimate environments.

Authors:  Shi-Yan Ren; Wen-Biao Wang; Ya-Guang Hao; Hao-Ran Zhang; Zhi-Chao Wang; Ye-Lin Chen; Rong-Ding Gao
Journal:  World J Clin Cases       Date:  2020-04-26       Impact factor: 1.337

5.  Impact of RNA Degradation on Viral Diagnosis: An Understated but Essential Step for the Successful Establishment of a Diagnosis Network.

Authors:  Damarys Relova; Liliam Rios; Ana M Acevedo; Liani Coronado; Carmen L Perera; Lester J Pérez
Journal:  Vet Sci       Date:  2018-02-06

6.  Evaluation of Saline, Phosphate-Buffered Saline, and Minimum Essential Medium as Potential Alternatives to Viral Transport Media for SARS-CoV-2 Testing.

Authors:  Kyle G Rodino; Mark J Espy; Seanne P Buckwalter; Robert C Walchak; Jeffery J Germer; Emily Fernholz; Aimee Boerger; Audrey N Schuetz; Joseph D Yao; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

7.  Comparative Performance of SARS-CoV-2 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit.

Authors:  Arun K Nalla; Amanda M Casto; Meei-Li W Huang; Garrett A Perchetti; Reigran Sampoleo; Lasata Shrestha; Yulun Wei; Haiying Zhu; Keith R Jerome; Alexander L Greninger
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

  7 in total
  8 in total

1.  Overcoming Supply Shortage for SARS-CoV-2 Detection by RT-qPCR.

Authors:  Gustavo Barcelos Barra; Ticiane Henriques Santa Rita; Pedro Góes Mesquita; Rafael Henriques Jácomo; Lídia Freire Abdalla Nery
Journal:  Genes (Basel)       Date:  2021-01-13       Impact factor: 4.096

2.  Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile.

Authors:  Carlos Barrera-Avalos; Roberto Luraschi; Eva Vallejos-Vidal; Maximiliano Figueroa; Esteban Arenillas; Daniela Barría; Felipe Hernández; Carlos Mateluna; Javier Mena; Claudia Rioseco; Claudia Torrent; Claudio Vergara; Gaby Gutiérrez; Javiera Quiroz; Javiera Alarcón; Julio Cartagena; Javiera Cayunao; Andrea Mella-Torres; Álvaro Santibañez; Sebastián Tapia; Alejandro Undurraga; Deborah Vargas; Valentina Wong; Ailen Inostroza-Molina; Daniel Valdés; Mónica Imarai; Claudio Acuña-Castillo; Felipe E Reyes-López; Ana M Sandino
Journal:  J Med Virol       Date:  2021-11-15       Impact factor: 20.693

3.  SARS-CoV-2 reliably detected in frozen saliva samples stored up to one year.

Authors:  Jennifer K Frediani; Kaleb B McLendon; Adrianna Westbrook; Scott E Gillespie; Anna Wood; Tyler J Baugh; William O'Sick; John D Roback; Wilbur A Lam; Joshua M Levy
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

4.  Evaluation and Clinical Validation of Guanidine-Based Inactivation Transport Medium for Preservation of SARS-CoV-2.

Authors:  Hesti L Wiraswati; Shabarni Gaffar; Savira Ekawardhani; Nisa Fauziah; Fedri R Rinawan; Leonardus Widyatmoko; Amila Laelalugina; Annissa R Arimdayu; Tri Kusniati; Clarisa D Andari; Lia Faridah
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-07-21

5.  Design and Numerical Analysis of a Graphene-Coated SPR Biosensor for Rapid Detection of the Novel Coronavirus.

Authors:  Tarik Bin Abdul Akib; Samia Ferdous Mou; Md Motiur Rahman; Md Masud Rana; Md Rabiul Islam; Ibrahim M Mehedi; M A Parvez Mahmud; Abbas Z Kouzani
Journal:  Sensors (Basel)       Date:  2021-05-17       Impact factor: 3.576

6.  Detection of SARS-CoV-2 by real-time PCR under challenging pre-analytical conditions reveals independence of swab media and cooling chain.

Authors:  Sabrina Summer; Ralf Schmidt; Anna Nele Herdina; Isabella Krickl; Julia Madner; Georg Greiner; Florian J Mayer; Nicole Perkmann-Nagele; Robert Strassl
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

7.  SARS-CoV-2 RNA stability in dry swabs for longer storage and transport at different temperatures.

Authors:  Alonzo Alfaro-Núñez; Stephanie Crone; Shila Mortensen; Maiken Worsøe Rosenstierne; Anders Fomsgaard; Ellinor Marving; Sofie Holdflod Nielsen; Michelle Grace Pinto Jørgensen; Charlotta Polacek; Arieh S Cohen; Claus Nielsen
Journal:  Transbound Emerg Dis       Date:  2021-10-11       Impact factor: 4.521

8.  Multicenter Technical Validation of 30 Rapid Antigen Tests for the Detection of SARS-CoV-2 (VALIDATE).

Authors:  Gilbert Greub; Giorgia Caruana; Michael Schweitzer; Mauro Imperiali; Veronika Muigg; Martin Risch; Antony Croxatto; Onya Opota; Stefanie Heller; Diana Albertos Torres; Marie-Lise Tritten; Karoline Leuzinger; Hans H Hirsch; Reto Lienhard; Adrian Egli
Journal:  Microorganisms       Date:  2021-12-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.